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In previous work, we engineered functional cell sheets using bone marrow-derived mesenchymal stem cells 
(BM-MSCs) to promote islet graft survival. In the present study, we hypothesized that a cell sheet using dermal 
fibroblasts could be an alternative to MSCs, and then we aimed to evaluate the effects of this cell sheet on the 
functional viability of human islets. Fibroblast sheets were fabricated using temperature-responsive culture 
dishes. Human islets were seeded onto fibroblast sheets. The efficacy of the fibroblast sheets was evaluated by 
dividing islets into three groups: the islets-alone group, the coculture with fibroblasts group, and the islet cul-
ture on fibroblast sheet group. The ultrastructure of the islets cultured on each fibroblast sheet was examined by 
electron microscopy. The fibroblast sheet expression of fibronectin (as a component of the extracellular matrix) 
was quantified by Western blotting. After 3 days of culture, islet viabilities were 70.2 ± 9.8%, 87.4 ± 5.8%, and 
88.6 ± 4.5%, and survival rates were 60.3 ± 6.8%, 65.3 ± 3.0%, and 75.8 ± 5.6%, respectively. Insulin secretions 
in response to high-glucose stimulation were 5.1 ± 1.6, 9.4 ± 3.8, and 23.5 ± 12.4 μIU/islet, and interleukin-6 
(IL-6) secretions were 3.0 ± 0.7, 5.1 ± 1.2, and 7.3 ± 1.0 ng/day, respectively. Islets were found to incorporate 
into the fibroblast sheets while maintaining a three-dimensional structure and well-preserved extracellular 
matrix. The fibroblast sheets exhibited a higher expression of fibronectin compared to fibroblasts alone. In con-
clusion, human dermal fibroblast sheets fabricated by tissue-engineering techniques could provide an optimal 
substrate for human islets, as a source of cytokines and extracellular matrix.
Key words: Islets; Fibroblasts; Cell sheet; Tissue engineering; Cell transplantation
INTRODUCTION
The outcomes of islet transplantation have improved 
significantly since the introduction of the Edmonton pro-
tocol in 20001, but the long-term survival of the trans-
planted islet b cells has not been satisfactory2. There are 
several disadvantages of intraportal islet transplanta-
tion, including an instant blood-mediated inflammatory 
reaction3, the risk of exposure to high concentrations of 
immunosuppressive drugs4, and complications such as 
portal vein thrombosis and bleeding5,6. To overcome these 
disadvantages, researchers have attempted to transplant 
islets into extrahepatic sites including the kidney cap-
sule, pancreas, spleen, omental pouch, testis, thymus, and 
subcutaneous locations7–15. Among them, the subcutane-
ous sites are ideal because of the minimal invasiveness 
involved. In addition, islets transplanted into a subcutane-
ous site can be removed easily and biopsied if needed.
However, the outcomes of islet transplantation into 
subcutaneous sites are still unsatisfactory because of poor 
vascularization, which restricts the blood supply to the 
graft. To create a vascularized subcutaneous site, several 
biomaterials combined with growth factors such as vas-
cular endothelial growth factor (VEGF) and fibroblast 
growth factor (FGF) have been developed9,10,14,16–19.
To overcome the poor vascularization in the sub-
cutaneous site, we developed a method for performing 
islet transplantation using tissue-engineered cell sheet of 
islets and bone marrow-derived mesenchymal stem cells 
(BM-MSCs), and succeeded in the reversal of diabetes 
mellitus (DM) in a rodent model20. A cell sheet has a 
trophic effect, and it preserves the endogenous extracel-
lular matrix (ECM) and adhesive factors21,22.
Before this technique can be applied in clinical set-
tings, it is necessary to determine the effects of the cell 
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sheets on human islets and to identify more convenient 
cell sources as a substrate. In the present study, we used 
human dermal fibroblasts for this purpose because fibro-
blasts can be harvested easily and are known to play 
important roles in promoting vascularization through 
the secretion of VEGF and FGF and to improve islet 
viability23–26. We fabricated cell sheets using human der-
mal fibroblasts, and we investigated the effects of the cell 
sheets on the viability and functioning of human islets.
MATERIALS AND METHODS
Islet Isolation and Shipment
Human islets were isolated from consenting multi organ 
deceased donors at the University of Alberta as previously 
described27 with intent for clinical transplantation, and 
were only made available for research when the islet yield 
fell below that of the minimal mass required for clinical 
transplantation as previously described28. The human islets 
isolated at the University of Alberta were then shipped by 
air to Nagasaki University in accordance with the guide-
lines of the Ethics Committee at the University of Alberta. 
Consent for the research use of the islets was obtained from 
the donors’ relatives. All experiments were conducted at 
Nagasaki University in accordance with the guidelines of 
the Ethics Committee at the Nagasaki University Graduate 
School of Biomedical Sciences.
Cell Culture
The shipped human islets were cultured at 37°C 
under 5% CO2 overnight in CMRL-1066 medium 
(Mediatech, Manassas, VA, USA) supplemented with 
10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA, 
USA), 100 U/ml penicillin, and 100 μg/ml streptomycin 
(Invitrogen) before their use in this study. Human der-
mal fibroblasts (TIG-118 cells) were purchased from the 
Japanese Collection of Research Bioresources Cell Bank 
(Osaka, Japan). TIG-118 cells were cultured in minimum 
essential medium (MEM) (Invitrogen) supplemented 
with 10% FBS (Invitrogen), 100 U/ml penicillin, and 
100 μg/ml streptomycin (Invitrogen) at 37°C in a humidi-
fied air atmosphere with 5% CO2.
Fabrication of Cocultured Fibroblast Sheets With 
Human Islets
We seeded fibroblasts at a density of 5.0 ´ 105 cells/
dish onto a 35-mm- diameter temperature-responsive cul-
ture dish (UpCell®; CellSeed, Tokyo, Japan) with 2 ml of 
MEM. After the fibroblasts were cultured for 72 h, the 
MEM was removed and the human islets were seeded onto 
fibroblasts with 2 ml of CMRL-1066 medium. Following 
an additional cocultivation at 37°C in a humidified air 
atmosphere with 5% CO2 for 72 h, the human islets spon-
taneously detached together with the fibroblasts as a cell 
sheet by a transfer of the temperature-responsive culture 
dish to another incubator at 20°C for 1–2 h.
The islets were divided into three groups: the islets-
alone group, the coculture with fibroblasts group (the 
islets-with-fibroblasts group), and the islet culture on 
fibroblast sheet group (the islets-on-fibroblast-sheet 
group). The culture conditions of each group are shown in 
Figure 1. In the islets-alone group, 500 human islets were 
cultured in a 35-mm dish with an ultralow-attachment 
surface (Corning Life Sciences, Corning, NY, USA) with 
2 ml of CMRL-1066 medium. In the islets-with-fibroblasts 
group, 500 human islets were cocultured with preseeded 
fibroblasts in a 35-mm dish with an ultralow-attachment 
surface with 2 ml of CMRL-1066 medium. In the islets-
on-fibroblast-sheet group, 500 human islets were seeded 
onto a 35-mm temperature-responsive culture dish with 
preseeded fibroblasts with 2 ml of CMRL-1066 medium. 
In the latter two groups, 5.0 ´ 105 fibroblasts were pre-
seeded and cultured for 72 h before the cocultivation with 
human islets in MEM.
Immunohistochemistry
Immunohistochemistry by insulin staining was per-
formed to confirm the presence of b cells on the har-
vested cell sheets. After detachment of the fibroblast 
Figure 1. Illustrations of islet culture groups. (A) Islets-alone group. Human islets were cultured in a 35-mm dish with an ultralow-
attachment surface. (B) Islets-with-fibroblasts group. Human islets were cocultured with fibroblasts in a 35-mm dish with an ultralow-
attachment surface. (C) Islets-on-fibroblast-sheet group. Human islets were seeded onto a 35-mm temperature-responsive culture dish.
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sheet cultured with human islets was achieved by decreas-
ing the temperature, each cell sheet was fixed with 4% 
paraformaldehyde (PFA; Wako Pure Chemical Industries 
Ltd., Osaka, Japan). Cell sheets were embedded in par-
affin (Paraplast Plus; Leica Biosystems Inc., Richmond, 
IL, USA). Hematoxylin and eosin (H&E; Muto Pure 
Chemicals Co. Ltd., Tokyo, Japan) staining was per-
formed according to the standard staining protocol. For 
immunological staining, the sections were deparaf-
finized with xylene and rehydrated with graded ethanol. 
After treatment with preheated antigen retrieval solu-
tion (Dako, Glostrup, Denmark), the slides were allowed 
to cool at room temperature (RT) for 40 min, and then 
were treated with peroxidase-blocking solution (Dako) at 
room temperature (RT) for 10 min. Mouse monoclonal 
anti-human insulin antibody (1:100 dilution; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) was used as the pri-
mary antibody. After reaction with the primary antibody at 
RT for 120 min, the sections were treated with a horserad-
ish peroxidase (HRP)-labeled polymer conjugated to goat 
anti-mouse immunoglobulins (Dako) at RT for 60 min. 
Then the sections were stained with 3,3-diaminobenzidine 
tetrahydrochloride (DAB) containing hydrogen peroxide 
(Dako). The results of the staining were observed under an 
inverted microscope (Nikon, Tokyo, Japan).
Islet Viability and Survival Assay
In each group, 3 days after the start of the islet cul-
ture, calcein-acetoxymethyl (AM) and propidium iodide 
(PI) (Cellstain Double Staining Kit; Dojindo, Kumamoto, 
Japan) were used to analyze the viability of the islets. The 
assay solution was prepared as previously described20. The 
percentage of viable cells in each islet was counted under a 
fluorescence microscope (Nikon). For viability assay, five 
individual experiments were performed for each group. 
Total viability was calculated by dividing the number of 
viable cells by the number of all cells assessed. Because it 
is well known that the islet mass decreases during culture27, 
we evaluated the islet survival rate by assessing the islet 
mass based on islet equivalents at baseline and on day 3 
and day 7 after the cultures. For survival assays, six indi-
vidual experiments were performed for each group.
Insulin Secretion Assay
Three days after the islets were cultured, we conducted 
a glucose-stimulated insulin secretion test for each group. 
Krebs solution was prepared by adding together 25 mM 
2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic 
acid (HEPES), 115 mM NaCl, 24 mM NaHCO3, 5 mM 
KCl, 1 mM MgCl2 · 6H2O, 0.1% bovine serum albumin 
(BSA), and 2.5 mM CaCl2 · 2H2O (Wako Pure Chemical 
Industries). Islets were sequentially incubated in Krebs 
solution containing 2.8, 28, and then 2.8 mM glucose 
again; each incubation period was 1 h. The supernatant 
was collected after each incubation, and the amount of 
insulin secreted was measured by an enzyme-linked 
immunosorbent assay (ELISA) (ELISA Kit; Abcam, 
Cambridge, MA, USA) according to the manufacturer’s 
instructions. The stimulation index was calculated by 
dividing the amount of insulin secreted under the high-
glucose concentration by that under the initial low- 
glucose concentration. The data were obtained from six 
individual experiments.
Measurement of Cytokine Secretions
Three days after the start of the islet culture, the cul-
ture media were collected and frozen at −80°C until they 
were used for assays. We used an ELISA Kit (Abcam) 
to measure the secretions of the human cytokines trans-
forming growth factor-b1 (TGF-b1) and interleukin-6 
(IL-6) according to the manufacturer’s instructions. Five 
individual experiments were performed for the TGF-b1 
assay, and eight individual experiments were performed 
for the IL-6 assay.
Western Blot Analysis
Fibronectin (FN) is an ECM protein that is known to 
mediate a cellular interaction29. The expression of FN in 
fibroblast sheets was evaluated by Western blot. Fibroblasts 
were seeded at a density of 5.0 ´ 105 cells/dish onto 
35-mm-diameter temperature-responsive culture dishes 
or 35-mm-diameter dishes with an ultralow-attachment 
surfaces with 2 ml of MEM. Following a 72-h culture 
period, the fibroblasts and fibroblast sheets were col-
lected from the dishes and lysed with Triton-deoxycholate 
(DOC) lysis buffer (Sigma-Aldrich, St. Louis, MO, 
USA). The supernatant was collected and stored at −80°C 
until analysis after centrifugation. The measurement of 
protein was performed with a bicinchoninic acid assay 
(BCA) kit (Pierce, Rockford, IL, USA), and the protein 
was mixed with loading buffer, followed by incubation 
at 95°C for 5 min. The 8% acrylamide gels were used for 
sodium dodecyl sulfate–polyacrylamide gel electropho-
resis (SDS-PAGE). The proteins were transferred onto 
Immobilon-P membranes (Merck Millipore, Bedford, 
MA, USA), followed by blocking with 5% skim milk 
(MEGMILK SNOW BRAND Co. Ltd., Tokyo, Japan) in 
TBST [10 mM Tris-HCl, pH 7.8 (Nacalai Tesque, Kyoto, 
Japan), 100 mM NaCl (Wako Pure Chemical Industries), 
0.1% Tween 20 (Wako Pure Chemical Industries)] for 
60 min at RT. The membranes were incubated with rabbit 
polyclonal anti-FN antibody (1:500 dilution; Abcam) at 
4°C overnight, and then incubated with HRP-conjugated 
secondary antibody (1:2,500 dilution; GE Healthcare, 
Buckinghamshire, UK) for 90 min at RT. The protein 
was visualized using ECL Prime detection reagent (GE 
Healthcare). b-Actin was used as a loading control. The 
expression of FN was quantified using ImageJ software 
Delivered by Ingenta to: Nagasaki University
IP: 133.45.160.152 On: Mon, 08 May 2017 07:16:20
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
1528 MATSUSHIMA ET AL.
[National Institutes of Health (NIH), Bethesda, MD, 
USA]. The data were obtained from four individual 
experiments. A detailed description of the methods was 
previously described30.
Electron Microscopy Analysis
After the culture of the islets on fibroblast sheets 
for 3 days, each cell sheet was fixed and dehydrated as 
described20. For scanning electron microscopy (SEM), 
each dehydrated cell sheet was treated with t-butyl alco-
hol, followed by freeze drying. The surface of each cell 
sheet was coated with gold and observed under an electron 
microscope (JSM-6700F; JEOL, Tokyo, Japan). For trans-
mission electron microscopy (TEM), the dehydrated cell 
sheets were embedded in Epon 812 (TAAB Laboratories 
Equipment Ltd., Berkshire, UK), and the sections were 
cut with an ultramicrotome (Ultracut S; Leica, Vienna, 
Austria). After being stained with uranyl acetate (Cerac 
Inc., Milwaukee, WI, USA) and lead nitrate (Wako Pure 
Chemical Industries), the cell sheets were observed under a 
transmission electron microscope (JSM-1210; JEOL).
Statistical Analysis
The statistical analyses were accomplished using 
GraphPad PRISM6 for Mac (GraphPad Software, San 
Diego, CA, USA). The data are expressed as means ± 
standard deviation (SD). All data were collected in at 
least four individual experiments. The data were analyzed 
using an analysis of variance (ANOVA) with Tukey’s 
multiple comparison test when comparing more than two 
groups, and unpaired t-tests when comparing two groups. 
A value of p < 0.05 was considered significant.
RESULTS
Characteristics of Cocultured Fibroblast Sheets 
With Human Islets
Upon their arrival, we confirmed the morphological 
integrity of the human islets shipped from the University of 
Alberta by performing dithizone (DTZ) staining (Fig. 2A). 
The fibroblasts (5.0 × 105 cells) seeded onto 35-mm 
temperature-responsive culture dishes proliferated and 
became confluent within 3 days (Fig. 2B). Three days after 
the start of the fibroblast culture, we seeded human islets 
on the fibroblasts (Fig. 2C). The morphological integrity 
of the human islets cultured on the fibroblasts was further 
confirmed at this stage using DTZ staining (Fig. 2D).
The human islets adhered to the fibroblast sheet 
within 3 days, and each fibroblast sheet was detached 
without the islets dropping off when the temperature was 
decreased to 20°C (Fig. 2E, F). A histological exami-
nation revealed the presence of intact islets attached to 
each fibroblast sheet (Fig. 2G) as well as insulin-positive 
cells within the islets (Fig. 2H).
Effects of Coculturing With Fibroblasts or Fibroblast 
Sheets on the Survival and Viability of Human Islets
To determine whether coculturing with fibroblasts or 
a fibroblast sheet improves islet viability, we performed 
a viability assay after 3 days of culture. Figure 3A shows 
the results of the calcein-AM and PI double staining after 
3 days of cultivation. In the islets-alone group, the major-
ity of cells located in the central area of the islets were 
dead. Smaller numbers of islets were dead in the islets-
with-fibroblasts group and in the islets-on-fibroblast-
sheet group. The islet viability values of the islets-alone, 
islets-with-fibroblasts, and islets-on-fibroblast-sheet groups 
were 70.2 ± 9.8%, 87.4 ± 5.8%, and 88.6 ± 4.5%, respec-
tively, with significant differences (Fig. 3B).
The islet survival rates are shown in Figure 3C. The 
islet survival rate of the islets-on-fibroblast-sheet group 
was significantly higher than that of the islets-alone group 
at both 3 and 7 days after the cultivation.
Promoted Insulin Secretion by Coculture 
With Fibroblast Sheet
To investigate the effect of coculturing with fibro-
blasts or a fibroblast sheet on islet function, we per-
formed the insulin secretion test on day 3. As shown 
in Figure 4A, the insulin secretion by the islets-with- 
fibroblasts group was significantly higher than that of the 
islets-alone group during the high-glucose incubation. 
In the islets-on-fibroblast-sheet group, the insulin secre-
tion was significantly promoted at each concentration of 
glucose compared to the islets-alone group. As a result, 
the stimulation index of the islets-on-fibroblast-sheet 
group was significantly higher than those of the other two 
groups (Fig. 4B).
Promoted Cytokine Secretion by Coculture 
With Fibroblasts or Fibroblast Sheet
The cytokine secretion results are shown in Figure 4C 
and D. The islets-with-fibroblasts group exhibited signif-
icantly higher TGF-b1 secretions compared to the islets-
alone group. The islets-on-fibroblast-sheet group showed 
higher TGF-b1 secretions than the islets-alone group, but 
the difference was not significant. The levels of IL-6 of 
both the islets-on-fibroblast sheet group and the islets-
with-fibroblasts group were significantly higher than that 
of the islets-alone group.
Elevated Expression of FN in the Fibroblast Sheet
To investigate the production of FN in the fibroblast 
sheets, we analyzed the protein expression of FN. The 
results of the Western blot analysis showed a higher 
expression of FN in the fibroblast sheets (Fig. 5A and B), 
suggesting that the fabrication of the fibroblast sheet pro-
motes the production of FN.
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Figure 2. Characterization of human islets cultured on fibroblast sheets. (A) Shipped human islets were stained with DTZ for char-
acterization. Scale bar: 100 μm. (B) Fibroblasts seeded onto a 35-mm temperature-responsive culture dish grew to confluence within 
3 days. Scale bar: 500 μm. (C) The seeded human islets adhered to the fibroblast sheet. Scale bar: 500 μm. (D) Human islets on the 
fibroblast sheets were stained with DTZ for characterization. Scale bar: 200 μm. (E, F) Cocultured fibroblast sheets with human islets 
could be harvested without dropping the islets off by decreasing the temperature. Scale bars: 200 μm (E), 1 cm (F). (G) H&E staining 
of a detached cocultured fibroblast sheet with human islets. Scale bar: 200 μm. (H) b Cells of islets cultured on the fibroblast sheets 
were stained with insulin. Scale bar: 200 μm.
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Figure 3. The results of the islet viability and recovery rate assay. (A) Double staining by calcein-AM and PI was performed. Smaller 
numbers of dead cells were observed in the islets-with-fibroblasts group and the islets-on-fibroblast-sheet group compared to the islets-
alone group. Scale bar: 100 μm. (B) The islet viability of both the islets-with-fibroblasts group (n = 5) and the islets-on-fibroblast-sheet 
group (n = 5) was significantly higher than that of the islets-alone group (n = 5). *p < 0.05, **p < 0.01. (C) The islet survival rates of 
both the islets-with-fibroblasts and islets-on-fibroblast-sheet groups were significantly higher than that of the islets-alone group at 3 
and 7 days after the cultivation. *p < 0.05, **p < 0.01, ***p < 0.001; n = 6 for each group.
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Figure 4. The insulin secretion test results and the cytokine secretion values. (A) The secretion of insulin stimulated by each concen-
tration of glucose solution in the islets-on-fibroblast-sheet group was significantly higher than that in the islets-alone group. *p < 0.05, 
**p < 0.01; n = 6. (B) The stimulation index of the islets-on-fibroblast-sheet group was significantly higher than those of the islets-
with-fibroblasts and islets-alone groups. *p < 0.05. (C) The amount of TGF-b1 secreted in the islets-with-fibroblasts group was signifi-
cantly higher than that of the islets-alone group. **p < 0.01. The islets-on-fibroblast sheet group exhibited higher TGF-b1 secretions 
(but not significantly) compared to the islets-alone group; n = 5. (D) The amounts of IL-6 secreted by the islets-with-fibroblasts and 
islets-on-fibroblast-sheet groups were significantly higher than that of the islets-alone group. **p < 0.01, ****p < 0.0001; n = 8. NS, 
not significant.
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Ultrastructure of the Islets Embedded 
on the Fibroblast Sheet
We used SEM and TEM to investigate the morphol-
ogy of human islets cultured on the fibroblast sheets. The 
SEM revealed that the islets embedded on a fibroblast 
sheet were in round or oval shape, maintaining their 
three-dimensional (3D) structure (Fig. 5C, D). ECM 
was observed on the inferior surface of the fibroblast 
sheets (Fig. 5E, F). We used TEM to observe the cell-
to-cell connections, and we found that the cell-to-cell 
Figure 5. The elevated expression of FN in the fibroblast sheet and the preserved 3D structure of islets on the fibroblast sheet. (A) The 
Western blot analysis showed that the expression of FN in the fibroblast sheets was stronger than that in the fibroblasts. (B) The expres-
sion of FN in the fibroblast sheets was significantly higher than that in the fibroblasts. *p < 0.05; n = 4. (C, D) SEM demonstrated that 
the islets-on-fibroblast-sheets maintained a 3D structure. Scale bars: 200 μm (C), 100 μm (D). (E, F) The ECM was observed as a 
fibrous structure on the inferior side of the fibroblast sheets. Scale bars: 30 μm (E), 20 μm (F).
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connections within the islets were maintained via tight 
junctions (Fig. 6A, B). Each fibroblast cell adhered via 
a tight junction, a gap junction, a desmosome, and an 
ECM (Fig. 6C, D). The ECM and adherens junctions 
were observed in the boundary between the islets and 
the TIG-118 dermal fibroblast cells (Fig. 6E, F). These 
results suggest that the islets adhered to the fibroblast 
sheets via the ECM and that cell–cell adhesion was 
maintained by adhesion factors.
DISCUSSION
The results of the present study demonstrated that the 
cocultivation of islets with a fibroblast sheet can improve 
islet survival and function in vitro. Dermal fibroblasts 
could be an optimal cell source of cytokines, and dermal 
fibroblast sheets may have a protective effect on human 
islets as a 2D substrate with abundant ECM proteins.
Previous studies demonstrated that coculture with MSCs 
improved islet survival and function via cytoprotective 
Figure 6. TEM of cocultured fibroblast sheets with human islets. (A, B) The insulin granules were observed in the cytoplasm of 
b cells of the islets. Each b cell connected via a tight junction (white arrowheads). Scale bars: 1 μm (A, B). (C, D) Each fibroblast 
cell connected via a gap junction (black arrowhead), a desmosome (white arrows), and an ECM. Scale bars: 1 μm (C), 2 μm (D). 
(E, F) ECM and adherens junction (black arrows) were observed in the boundary between b cells and fibroblasts. Scale bars: 1 μm 
(E, F). TJ, tight junction; N, nucleus; F, fibroblast; GJ, gap junction; AJ, adherens junction.
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effects by the secretion of several growth factors31–34. In 
the present study, we used dermal human fibroblasts as 
a cell source for the production of cytokines. The main 
reason for this choice of cells was that dermal fibroblasts 
can be easily harvested from the skin, and they expand 
rapidly ex vivo. Fibroblasts are also well known to play 
an important role in wound healing by the secretion of 
several cytokines35. Therefore, similarly to MSCs, fibro-
blasts seem to have protective effects that are condu-
cive to islet survival and function. The present findings 
demonstrated elevated secretions of TGF-b and IL-6 in 
islets cocultured with fibroblasts. The role of TGF-b in 
the production of ECM has been revealed, and TGF-b1 
gene therapy has been shown to have a protective effect 
on islet survival36–38.
IL-6 is one of the cytokines involved in inflammation, 
not only in the immune system but also in the nonimmune 
events in many types of tissue39. The serum IL-6 levels of 
individuals with DM are known to be elevated, contribut-
ing to their insulin resistance40. However, it was reported 
that IL-6 enhances insulin secretion by promoting gluca-
gon-like peptide-1 (GLP-1) secretion41. Moreover, IL-6 
secreted by MSCs has been known to be elevated when 
they are cocultured with damaged cells, and IL-6 is con-
sidered to have an antiapoptotic effect on islets31,42. Our 
present findings that coculture with fibroblasts improved 
islet viability and increased the insulin secretion by the 
secretion of cytokines are thus consistent with these pre-
vious studies, and these protective effects of fibroblasts 
may resemble those of MSCs.
In the field of cell transplantation, cell sheets created 
by tissue engineering have been developed in clinical 
research43,44. Compared to cell injection methods, cell 
sheets are known to demonstrate a higher degree of cell 
viability and engraftment at subcutaneous sites by vas-
cularization via the secretion of angiogenic factors45. 
It was revealed in prior studies that islet sheets can be 
fabricated on a temperature-responsive dish using tissue-
engineering techniques and that islet sheets transplanted 
into a subcutaneous site could survive and improve blood 
glucose levels33,46.
A temperature-responsive dish is coated with poly 
(N-isopropyl acrylamide), which can change from hydro-
phobic to hydrophilic at temperatures under 32°C. Cells 
cultured on such a dish can thus be harvested as a cell sheet 
without tripsinization and then maintain cell-to-cell junc-
tions, preserving abundant ECM proteins that enhance 
the attachment of the cells to a subcutaneous site. The 
loss of native ECM proteins induced by enzymatic diges-
tion during islet isolation has been shown to contribute to 
graft dysfunction47, and it was reported that the viability 
and function of islets were improved by entrapping islets 
using ECM proteins48,49.
In the present study, the elevated expression of FN in 
the fibroblast sheets was demonstrated by Western blot-
ting, and the preserved cell-to-cell contact mediated by 
adherens-type junctions within islet cells was confirmed 
by TEM. FN is expressed in a variety of cells and medi-
ates a cellular interaction with ECM proteins29. The main 
function of FN in this setting was to enhance insulin 
secretion, whereas other ECM components such as a col-
lagen contribute to glucose metabolism50. It was reported 
that the cell-to-cell junctions play an important role in 
the maturation of b cells and insulin secretion51. In the 
present study, the islets cocultured with fibroblast sheets 
demonstrated higher viability, survival, and insulin secre-
tion compared to islets cocultured with fibroblasts (not 
in sheets). The preserved ECM proteins and elevated 
expression of FN in fibroblast sheets may account for the 
additional observed benefits in the islets-on-fibroblast-
sheet group.
In earlier studies, 3D scaffolds using biomaterials 
improved the survival and function of islets in vitro52,53. 
It was reported that 3D scaffolds reduced amyloid forma-
tion in human islet cultures54. In the present study, SEM 
revealed that human islets could be cultured while main-
taining a 3D structure on a fibroblast sheet. These results 
suggest that fibroblast sheets could be an alternative sub-
strate to maintain the natural structure of human islets and 
improve islet survival and functions.
In the field of regenerative medicine, islet transplanta-
tion could be an alternative therapeutic strategy to over-
come the shortage of donors. It was reported that MSCs, 
embryonic stem cells (ESCs), and induced pluripotent 
stem cells (iPSCs) could differentiate into insulin-pro-
ducing cells55–57, but the issue of safety regarding the tum-
origenicity or cancer progression induced by those stem 
cells in humans remains controversial58–61. To introduce 
the use of those stem cells as a regenerative medicine 
technique in clinical settings, subcutaneous transplanta-
tion sites may be optimal, because the cells could be easy 
to access when a transplanted graft must be removed. It 
was reported that dermal fibroblasts transplanted into a 
subcutaneous site did not demonstrate overgrowth within 
the ECM even after 60 days posttransplantation24.
In conclusion, fibroblast sheets have beneficial effects 
on the in vitro survival and functioning of human islets 
as a 2D substrate, through not only the secretion of sev-
eral cytokines but also the preservation of the ECM pro-
teins. Although further studies using an in vivo model are 
required, this novel fibroblast sheet method could be a use-
ful strategy in islet transplantation into subcutaneous sites.
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